The Restatement (Third) of Torts: Products Liability: the ALI's cure for prescription drug design liability.
"It has not been a well-kept secret. Anyone familiar with the law of products liability knows that [the Restatement (Second)] is out of date and requires revision." (1) "We conclude that [the Restatement (Third)] has no basis in the case law ... Accordingly, we do not adopt...

Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent.
HAMILTON, Bermuda, Jan. 16 /PRNewswire-FirstCall/ -- Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed a lawsuit against Sandoz Inc. ("Sandoz") in the District Court for the District of New Jersey for infringement of...

Review of Takeda's Febuxostat New Drug Application Continues Past PDUFA Date.
FDA has not completed routine investigator site and CRO vendor inspections OSAKA, Japan, Jan. 19 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification from the U.S. Food and Drug...

Lupin is Granted USFDA Approval for Levetiracetam Tablets.
BALTIMORE, Jan. 16 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets 250mg, 500mg, 750mg and 1000mg from the U.S. Food and Drug Administration (USFDA). Commercial shipments of the product have commenced. ...

Roxas welcomes entry of Indian drug company.
Sen. Manuel A. Roxas II yesterday welcomed the entry of an Indian pharmaceutical company in the local market which he says will help provide quality medicine at lower costs to the public. Roxas issued the statement after India's leading integrated pharmaceutical company, Zydus Cadila Healthcare Ltd., formally...

Stories From Our Foremothers: deCODE Publishes an Unparalleled Genetic Snapshot of Iceland 1000 Years Ago.
REYKJAVIK, Iceland, Jan. 16 /PRNewswire-FirstCall/ -- In a paper published today scientists at deCODE genetics present the results of the largest study of ancient DNA from a single population ever undertaken. Analyzing mitochondrial DNA, which is passed from mother to offspring, from 68 skeletal remains from approximately 1000 years...

Immtech Announces Sale of Property Subsidiary in China.
NEW YORK, Jan. 16 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has entered into an agreement to sell Immtech Life Science Limited, a subsidiary of the Company which owns land use rights and property in Shenzhen, China, to a third party. Under...

NUCRYST Pharmaceuticals appoints a new director.
PRINCETON, NJ, Jan. 16 /PRNewswire-FirstCall/ -- Thomas E. Gardner, Chairman, announced today that G. A. (Drew) Fitch has been appointed to the NUCRYST Pharmaceuticals' Board of Directors. Mr. Fitch is the President and Chief Executive Officer of The Westaim Corporation ("Westaim"), NUCRYST's controlling shareholder, holding approximately 75%...

Malaria: New Treatment is Upcoming.
Developed by the Italian Pharmaceutical Company sigma-tau New Data Confirm the Absence of Side Effects and the Benefit of the Simpler Treatment Schedule ROME, January 16 /PRNewswire/ -- The results of two new large scale trials show that the combination of dihydroartemisinin and piperaquine (DHA+PQP)...

DSWD trains visually impaired people.
CEBU CITY -- The Department of Social Welfare and Development in Region 7 (DSWD-7), through its Area Vocational Rehabilitation Center (AVRC), is eyeing to train more visually impaired students to hone their skills that will allow them to have an income. Jaybee Carillo, DSWD-7 information officer, said...